Step 3: Contact your healthcare provider Bring your symptom documentation to your provider
As retatrutide has still not been launched yet, the exact doses of the medication have not been decided, but a common titration schedule for retatrutide may look like: Weeks 14: 1 mg per week Weeks 58: 2 mg per week Weeks 912: 4 mg per week Weeks 12 plus, higher doses of 8mg and highest doses of 12mg may be achieved This structured dosing aims to enhance safety and effectiveness
However, it is critical to provide your full medical history, including all known allergies, to your healthcare provider and pharmacist
The approval process is lengthy, and retatrutide is likely to be unavailable until late 2024 or later, contingent on trial results and the speed of regulatory review
Do not use solution that appears different from when you initially reconstituted it
The liver benefits likely stem from glucagon receptor activation directly on hepatocytes (liver cells)